[sheet: Filing Overview]

[sheet: Filing Overview]
Filing No. | Regulatory Body | Filing Type | Jurisdiction | Filing Reference / Case No. | Applicable Statute / Regulation | Filing Party / Parties | Outside Counsel Responsible | Lead Contact at Counsel | C&H Lead | Filing Date | Initial Review Period | Review Period Expiry Date | Second Phase / Extended Review Possible | Second Phase Period | Anticipated Second Phase Trigger Date | Earliest Possible Clearance Date | Latest Possible Clearance Date | Current Status | Status as of Date | Filing Fee | Fee Paid By | Condition Precedent to Closing | Outside Date | Extended Outside Date | Notes / Comments
1 | Federal Trade Commission (FTC) | HSR Act Premerger Notification | United States | HSR-20250328-4192 | Hart-Scott-Rodino Antitrust Improvements Act of 1976; 15 U.S.C. §18a | Ardent Apex Holdings Inc. / Luminex Systems Holdings Inc. | Calderwood & Harkness LLP | Elaine Forsythe (Antitrust Partner) | Elaine Forsythe | 2025-03-28 | 30 calendar days | 2025-04-27 | Yes | Additional 30 days from substantial compliance with Second Request | ~2025-04-25 (anticipated Second Request issuance) | July 2025 (estimated, assuming substantial compliance ~60 days post-Second Request) | September 10, 2025 (Outside Date) | Second Request anticipated; initial 30-day waiting period expires April 27, 2025. DOJ cleared matter to FTC on April 2, 2025. Combined market share ~25% in procurement-automation SaaS (Luminex ~18% + Vectis Solutions LLC ~7%) likely to trigger Second Request. | 2025-04-15 | $2,390,000 | Ardent Capital Partners III LP (Buyer) | Yes | 2025-09-10 | 2025-12-10 | Antitrust overlap with Ardent Fund II portfolio company Vectis Solutions LLC (CEO: Michael Parekh; 2024 revenue: $68M; ~7% procurement SaaS market share). Remedies/divestiture analysis underway. See Second Request Preparation Memorandum and Remedies/Divestiture Analysis Memorandum.
2 | Committee on Foreign Investment in the United States (CFIUS) | Voluntary Joint Notice | United States | CFIUS-2025-0087 | Section 721 of the Defense Production Act; 31 C.F.R. Part 800 | Ardent Apex Holdings Inc. / Luminex Systems Holdings Inc. (joint notice) | Calderwood & Harkness LLP | James Prentice (M&A Partner) | James Prentice / Ryan Kowalski | 2025-04-04 | 45 calendar days (review period) | 2025-05-19 | Yes | Up to additional 45 days (investigation period) + 15-day Presidential review if escalated | N/A — to be determined based on CFIUS response | May 19, 2025 (if cleared in initial review) | September 10, 2025 (Outside Date) | Under 45-day review period. Basis: Luminex US holds contracts with three U.S. federal agencies — DOD (logistics software module), DOE (procurement platform), GSA (enterprise license) — constituting covered transactions under 31 C.F.R. Part 800. | 2025-04-15 | $0 | N/A (no filing fee for CFIUS voluntary notice) | Yes | 2025-09-10 | 2025-12-10 | Mitigation measures under evaluation (data security protocols, cleared-facility compliance, proxy board arrangements, government-contract carve-outs). See CFIUS Mitigation Strategy Memorandum.
3 | Swiss Competition Commission (COMCO) / SECO | Merger Control Notification / Lex Koller / SESTA Review | Switzerland | 32-0973 | Swiss Federal Act on Cartels (KartG); Lex Koller (Federal Act on the Acquisition of Real Estate by Persons Abroad); SESTA | Ardent Apex Holdings Inc. (via Breitfeld Hess & Partner AG) | Breitfeld Hess & Partner AG | Dr. Lukas Breitfeld | Megan Chu | 2025-04-07 | Phase I: 1 month (preliminary examination) | ~2025-05-07 | Yes | Phase II: up to 4 additional months | N/A — to be determined | May 2025 (if cleared in Phase I) | September 10, 2025 (Outside Date) | Phase I review. Combined Swiss revenues exceed CHF 100 million threshold. Luminex AG (CHE-284.391.057) headquartered at Bahnhofstrasse 71, 8001 Zürich. | 2025-04-15 | $0 | To be confirmed (Swiss filing fees nominal) | Yes | 2025-09-10 | 2025-12-10 | Coordination with Breitfeld Hess & Partner AG on both KartG merger control and Lex Koller analysis. See Swiss Filing Instruction Letter.
4 | Bundeskartellamt (German Federal Cartel Office) | Merger Control Notification | Germany | B6-34/25 | Gesetz gegen Wettbewerbsbeschränkungen (GWB) §35 | Ardent Apex Holdings Inc. (via Wendt Schäfer Rechtsanwälte PartG mbB) | Wendt Schäfer Rechtsanwälte PartG mbB | Dr. Katarina Wendt | Megan Chu | 2025-04-09 | Phase I: 1 month | ~2025-05-09 | Yes | Phase II: up to 4 additional months (extended examination) | N/A — to be determined | May 2025 (if cleared in Phase I) | September 10, 2025 (Outside Date) | Phase I review. Veltronix GmbH 2024 German revenue: €67,000,000; Vectis GmbH German revenue: €12,000,000; combined exceeds €500M worldwide / €25M domestic thresholds under GWB §35. Veltronix GmbH registered at Leopoldstrasse 120, 80802 Munich (HRB 247891). | 2025-04-15 | $0 | To be confirmed (German filing fees nominal) | Yes | 2025-09-10 | 2025-12-10 | Overlap with Vectis Solutions' German subsidiary (Vectis GmbH). See Bundeskartellamt Filing Instruction Letter.
5 | European Commission — DG Competition | EU Foreign Subsidies Regulation (FSR) Notification | European Union | FSR.M.2025-0412 | Regulation (EU) 2022/2560 (Foreign Subsidies Regulation) | Ardent Apex Holdings Inc. (via Breitfeld Hess & Partner AG) | Breitfeld Hess & Partner AG | Dr. Lukas Breitfeld | Megan Chu | 2025-04-11 | Preliminary review: 25 business days | ~2025-05-15 (estimated, 25 business days from April 11) | Yes | In-depth investigation: additional 90 working days (extendable by 15 working days) | N/A — to be determined | Mid-May 2025 (if cleared in preliminary review) | September 10, 2025 (Outside Date) | Preliminary review. EU turnover exceeds €500 million; foreign financial contributions exceed €50 million in aggregate (includes Ardent LP's limited-partner base of sovereign wealth and state-affiliated pension funds). | 2025-04-15 | $0 | To be confirmed | Yes | 2025-09-10 | 2025-12-10 | Novel regulatory regime; limited precedent. Coordination with Breitfeld Hess & Partner AG. See EU FSR Filing Instruction Letter.
[sheet: Detailed Timeline]
Date | Event / Milestone | Filing / Workstream | Responsible Party | Action Required | Deadline Type | Status | Notes
2025-03-05 | Ardent Apex Holdings Inc. incorporated (Delaware) | Corporate / Pre-Filing | Calderwood & Harkness LLP | Incorporation filing with DE Secretary of State | Internal | Completed | EIN: 93-2178435; Registered Agent: National Registered Agents of Delaware, Inc., 160 Greentree Drive, Suite 101, Dover, DE 19904
2025-03-07 | Ardent Apex Merger Sub Inc. incorporated (Delaware) | Corporate / Pre-Filing | Calderwood & Harkness LLP | Incorporation filing with DE Secretary of State | Internal | Completed | EIN: 93-2178502; Registered Agent: National Registered Agents of Delaware, Inc.
2025-03-08 | Debt commitment letter and fee letter executed (Stonebridge Credit Partners LLC) | Financing | Stonebridge Credit Partners LLC / Calderwood & Harkness LLP | Execution of commitment letter (Ref. SC-2025-0312-AC) for $1,400,000,000 senior secured credit facility | Contractual | Completed | Term Loan B: $1,200,000,000; Revolver: $200,000,000; Lead: Nathan Ostrowski
2025-03-10 | Matter opened; engagement letter signed | Administrative | Calderwood & Harkness LLP | Matter No. 1001-00004 opened; engagement letter with Ardent Capital Partners III LP executed | Internal | Completed | Responsible Partner: James Prentice; Billing Partner: Sandra Tung
2025-03-12 | Exclusivity agreement executed | Transaction | Calderwood & Harkness LLP / Caldwell, Raines & Sheppard LLP | Execution of exclusivity agreement between Ardent Capital and Luminex | Contractual | Completed
2025-03-24 | Merger Agreement executed | Transaction | All parties | Execution of Agreement and Plan of Merger among Ardent Apex Holdings Inc., Ardent Apex Merger Sub Inc., and Luminex Systems Holdings Inc. | Contractual | Completed | Reverse triangular merger; $2,800,000,000 equity value; $20.00 per share; 140,000,000 fully diluted shares
2025-03-28 | HSR Act premerger notification filed with FTC | HSR (Filing 1) | Calderwood & Harkness LLP (Elaine Forsythe) | File HSR notification form; pay filing fee of $2,390,000 | Statutory | Completed | Transaction No. HSR-20250328-4192. 30-day initial waiting period begins.
2025-04-02 | DOJ/FTC clearance allocation — matter cleared to FTC | HSR (Filing 1) | DOJ / FTC | None (agency action) | Statutory | Completed | FTC will conduct substantive review
2025-04-04 | CFIUS voluntary joint notice filed | CFIUS (Filing 2) | Calderwood & Harkness LLP (James Prentice / Ryan Kowalski) | File voluntary joint notice with CFIUS | Statutory | Completed | Tracking No. CFIUS-2025-0087. 45-day review period begins. Covered transaction basis: Luminex US federal agency contracts (DOD, DOE, GSA).
2025-04-07 | Swiss COMCO/SECO notification filed | Swiss (Filing 3) | Breitfeld Hess & Partner AG (Dr. Lukas Breitfeld) | File Swiss KartG merger control and Lex Koller notification | Statutory | Completed | File No. 32-0973. Phase I review (~1 month). Combined Swiss revenues exceed CHF 100M.
2025-04-09 | Bundeskartellamt filing submitted | Germany (Filing 4) | Wendt Schäfer Rechtsanwälte PartG mbB (Dr. Katarina Wendt) | File German merger notification | Statutory | Completed | File No. B6-34/25. Phase I review (1 month). Veltronix GmbH revenue: €67M; Vectis GmbH German revenue: €12M.
2025-04-11 | EU FSR notification filed | EU FSR (Filing 5) | Breitfeld Hess & Partner AG (Dr. Lukas Breitfeld) | File EU Foreign Subsidies Regulation notification | Statutory | Completed | Case No. FSR.M.2025-0412. Preliminary review: 25 business days. EU turnover >€500M; foreign financial contributions >€50M.
~2025-04-25 | Anticipated FTC Second Request issuance | HSR (Filing 1) | FTC | Prepare for Second Request compliance; activate document-hold and custodian identification | Statutory | Pending | Based on combined ~25% market share (Luminex ~18% + Vectis ~7%). Coordinate with Ardent Capital and Vectis Solutions LLC (CEO: Michael Parekh).
2025-04-27 | HSR initial 30-day waiting period expires | HSR (Filing 1) | FTC / Calderwood & Harkness LLP | If Second Request issued, new compliance timeline begins; if no action, HSR cleared | Statutory | Pending | Second Request expected to be issued before expiry, extending the review period.
~2025-05-07 | Swiss COMCO Phase I review period expires (estimated) | Swiss (Filing 3) | COMCO / Breitfeld Hess & Partner AG | Expect Phase I clearance or notice of Phase II investigation | Statutory | Upcoming
~2025-05-09 | Bundeskartellamt Phase I review period expires (estimated) | Germany (Filing 4) | Bundeskartellamt / Wendt Schäfer Rechtsanwälte | Expect Phase I clearance or notice of extended examination | Statutory | Upcoming
~2025-05-15 | EU FSR preliminary review period expires (estimated, 25 business days) | EU FSR (Filing 5) | European Commission / Breitfeld Hess & Partner AG | Expect preliminary clearance or opening of in-depth investigation | Statutory | Upcoming
2025-05-19 | CFIUS 45-day review period expires | CFIUS (Filing 2) | CFIUS / Calderwood & Harkness LLP | CFIUS clearance expected, or notice of 45-day investigation period, or request for mitigation agreement | Statutory | Upcoming | If investigation opened, additional 45 days + potential 15-day Presidential review.
~2025-06-25 | Estimated substantial compliance with FTC Second Request (~60 days post-issuance) | HSR (Filing 1) | Calderwood & Harkness LLP (Elaine Forsythe) | Certify substantial compliance with Second Request; new 30-day waiting period begins | Statutory | Upcoming | Assumes Second Request issued ~April 25. Coordination with Vectis Solutions for document production.
2025-07-01 | Target estimated closing — earliest (Q3 2025) | All Filings | All parties | All regulatory approvals must be obtained; closing deliverables prepared | Contractual | Upcoming | Estimated range: July–August 2025
~2025-07-25 | Estimated FTC clearance / consent decree (30 days post-substantial compliance) | HSR (Filing 1) | FTC / Calderwood & Harkness LLP | Obtain FTC clearance or negotiate consent decree / remedies | Statutory | Upcoming | Remedies negotiations may extend timeline. Divestiture of Vectis Solutions LLC or behavioral remedies under consideration.
2025-08-31 | Target estimated closing — latest (Q3 2025) | All Filings | All parties | All regulatory approvals must be obtained; closing deliverables prepared | Contractual | Upcoming
2025-09-10 | Outside Date (Drop-Dead Date) | All Filings / Merger Agreement | All parties | If closing has not occurred, either party may terminate the Merger Agreement (subject to extension right) | Contractual | Upcoming | Extendable by either party for up to 3 months (to December 10, 2025) if the sole unsatisfied condition is regulatory approval. Reverse termination fee of $140,000,000 if Buyer fails to close due to financing failure or willful breach; target termination fee of $84,000,000 if Target terminates for Superior Proposal.
2025-12-10 | Extended Outside Date (if regulatory extension exercised) | All Filings / Merger Agreement | All parties | Final drop-dead date if extended for regulatory delay | Contractual | Upcoming | Extension available only if sole unsatisfied condition is regulatory approval.
[sheet: Filing Detail — HSR]
Item | Detail
Filing Type | HSR Act Premerger Notification Form
Transaction No. | HSR-20250328-4192
Filing Date | March 28, 2025
Filing Fee | $2,390,000 (per 2025 HSR fee schedule, based on transaction value of $2,800,000,000)
Filing Fee Paid By | Ardent Capital Partners III LP (Buyer)
Reviewing Agency | Federal Trade Commission (FTC)
DOJ/FTC Clearance Date | April 2, 2025 (cleared to FTC)
Initial Waiting Period | 30 calendar days from filing date
Initial Waiting Period Expiry | April 27, 2025
Second Request Anticipated | Yes — ~April 25, 2025 (estimated)
Basis for Second Request | Combined market share of ~25% in procurement-automation SaaS: Luminex Systems (~18%) + Vectis Solutions LLC (~7%, Ardent Fund II portfolio company)
Vectis Solutions LLC | Ardent Fund II portfolio company; Delaware LLC; HQ: 4000 Shoreline Court, Suite 300, South San Francisco, CA 94080; CEO: Michael Parekh; EIN: 82-4910337; 2024 revenue: $68,000,000
Luminex Procurement SaaS Market Share | ~18%
Vectis Procurement SaaS Market Share | ~7%
Combined Market Share | ~25%
C&H Lead — Antitrust | Elaine Forsythe (Partner, Antitrust & Competition)
Seller's Antitrust Counsel | Gregory Lam (Partner, Caldwell, Raines & Sheppard LLP)
Second Request Preparation Status | Internal strategy memorandum prepared; document-hold and custodian identification underway; coordination with Ardent Capital and Vectis Solutions (Michael Parekh)
Remedies / Divestiture Analysis | Under evaluation — see Remedies/Divestiture Analysis Memorandum (internal, privileged)
FTC Timing Agreement | Draft letter prepared; to be submitted following Second Request issuance
Estimated Substantial Compliance | ~60 days post-Second Request issuance
Estimated Clearance Date | July–August 2025 (aligned with target closing)
Condition Precedent to Closing | Yes — expiration or early termination of HSR waiting period (including any Second Request)
Outside Date | September 10, 2025 (extendable to December 10, 2025 for regulatory delay)
[sheet: Filing Detail — CFIUS]
Item | Detail
Filing Type | Voluntary Joint Notice
Tracking No. | CFIUS-2025-0087
Filing Date | April 4, 2025
Filing Fee | N/A
Reviewing Body | Committee on Foreign Investment in the United States (CFIUS)
Filing Parties | Ardent Apex Holdings Inc. (Buyer) / Luminex Systems Holdings Inc. (Target) — joint notice
Applicable Regulation | Section 721 of the Defense Production Act; 31 C.F.R. Part 800
Basis for Filing | Luminex US holds contracts with three U.S. federal agencies constituting covered transactions: (1) Department of Defense — logistics software module; (2) Department of Energy — procurement platform; (3) GSA — enterprise license
Review Period | 45 calendar days from acceptance of notice
Review Period Expiry | May 19, 2025
Potential Investigation Period | Additional 45 calendar days if CFIUS opens investigation
Presidential Review | Up to 15 additional days if escalated to President
C&H Lead | James Prentice (Responsible Partner, M&A) / Ryan Kowalski (Lead Associate)
National Security Concerns | Access to U.S. government data and logistics/procurement systems; potential foreign influence on critical infrastructure software
Mitigation Measures Under Evaluation | Data security protocols; cleared-facility compliance; proxy board arrangements for government contract work; government-contract carve-outs
Co-Investor Consideration — Northvale | Northvale Sovereign Holdings Ltd. (Cayman Islands) — $200,000,000 co-invest; sovereign wealth / state-affiliated entity — may raise additional CFIUS scrutiny regarding beneficial ownership
Current Status | Under 45-day review period (filed April 4, 2025)
Estimated Clearance Date | May 19, 2025 (if cleared in initial review); later if investigation opened
Condition Precedent to Closing | Yes
Outside Date | September 10, 2025 (extendable to December 10, 2025)
[sheet: Filing Detail — Swiss]
Item | Detail
Filing Type | Merger Control Notification (KartG) / Lex Koller Review / SESTA
File No. | 32-0973
Filing Date | April 7, 2025
Reviewing Bodies | Swiss Competition Commission (COMCO); State Secretariat for Economic Affairs (SECO); FINMA (if applicable)
Applicable Statutes | Swiss Federal Act on Cartels and Other Restraints of Competition (KartG); Federal Act on the Acquisition of Real Estate by Persons Abroad (Lex Koller); Swiss Federal Act on Stock Exchanges and Securities Trading (SESTA)
Target Entity (Swiss) | Luminex Systems AG; Aktiengesellschaft; Commercial Register No. CHE-284.391.057; Bahnhofstrasse 71, 8001 Zürich, Switzerland
Filing Threshold Basis | Combined Swiss revenues exceed CHF 100 million threshold under KartG
Local Counsel | Breitfeld Hess & Partner AG, Talstrasse 62, 8001 Zürich; Lead: Dr. Lukas Breitfeld
C&H Coordinator | Megan Chu (Working Associate, M&A)
Phase I Review Period | ~1 month (preliminary examination)
Phase I Expiry (estimated) | ~May 7, 2025
Phase II (if triggered) | Up to 4 additional months
Key Considerations | Lex Koller: acquisition by foreign (U.S.) entity of Swiss company; SESTA: if Luminex AG shares are listed or otherwise regulated; KartG: horizontal overlap in enterprise SaaS procurement
Current Status | Phase I review
Estimated Clearance Date | May 2025 (if cleared in Phase I)
Condition Precedent to Closing | Yes
Outside Date | September 10, 2025 (extendable to December 10, 2025)
[sheet: Filing Detail — Germany]
Item | Detail
Filing Type | Merger Control Notification
File No. | B6-34/25
Filing Date | April 9, 2025
Reviewing Body | Bundeskartellamt (German Federal Cartel Office)
Applicable Statute | Gesetz gegen Wettbewerbsbeschränkungen (GWB) §35
Target Entity (Germany) | Luminex Systems GmbH; HRB 247891 (Munich); Leopoldstrasse 120, 80802 Munich, Germany
Veltronix GmbH 2024 German Revenue | €67,000,000
Vectis GmbH 2024 German Revenue | €12,000,000
Threshold Analysis | Combined worldwide revenues exceed €500 million; combined domestic (German) revenues exceed €25 million; each party exceeds €5 million domestic threshold — all three GWB §35 thresholds met
Local Counsel | Wendt Schäfer Rechtsanwälte PartG mbB, Maximilianstrasse 35, 80539 Munich; Lead: Dr. Katarina Wendt
C&H Coordinator | Megan Chu (Working Associate, M&A)
Phase I Review Period | 1 month
Phase I Expiry (estimated) | ~May 9, 2025
Phase II (if triggered) | Up to 4 additional months (extended examination)
Competitive Overlap | Procurement-automation SaaS — Veltronix GmbH + Vectis GmbH in German market
Current Status | Phase I review
Estimated Clearance Date | May 2025 (if cleared in Phase I)
Condition Precedent to Closing | Yes
Outside Date | September 10, 2025 (extendable to December 10, 2025)